Trimedyne Says Cosmetic Laser OKd

Trimedyne Inc. said it won approval from the Food and Drug Administration to market its new cosmetic laser. Shares of the Irvine-based company rose $2.28 to close at $5.50 in Nasdaq trading. The company said the new laser has possible uses that surpass those of any laser on the market, but it said it won’t disclose those uses until it officially unveils the laser in May.